In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 3, 2007, Pages 1102-1104

  Cercenado, Emilia ^a   Marín, Mercedes ^a   Sánchez Martínez, Mónica ^a   Cuevas, Oscar ^a   Martínez Alarcón, José ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; ERTAPENEM; IMIPENEM; LINEZOLID; MEROPENEM; MINOCYCLINE; MOXIFLOXACIN; TIGECYCLINE;

ANALYTIC METHOD; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NOCARDA FARCINICA; NOCARDIA; NOCARDIA ABSCESSUS; NOCARDIA ASTEROIDES; NOCARDIA BEIJINGENSIS; NOCARDIA BRASILIENSIS; NOCARDIA CARNEA; NOCARDIA FARCINICA; NOCARDIA NOVA; NOCARDIA OTITIDISCAVIARUM; NOCARDIA TRANSVALENSIS; NOCARDIA VETERANA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; NOCARDIA; NOCARDIA INFECTIONS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33847613300     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01102-06     Document Type: Article

References (21)

1. Ambaye, A., P. C. Kohner, P. C. Wollan, K. L. Roberts, G. D. Roberts, and F. R. Cockerill III. 1997. Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of Nocardia asteroides complex. J. Clin. Microbiol. 35: 847-852.
2. Biehle, J. R., J. R. Cavallieri, M. A. Sabolle, and L. J. Getsinger. 1994. Comparative evaluation of the Etest for susceptibility testing of Nocardia species. Diagn. Microbiol. Infect. Dis. 19:101-110.
3. Bradford, P. A., P. J. Petersen, M. Young, C. H. Jones, M. Tichler, and J. O'Connell. 2005. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method. Antimicrob. Agents Chemother. 49:3903-3909.
4. Brown-Elliott, B. A., J. M. Brown, P. S. Conville, and R. J. Wallace, Jr. 2006. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin. Microbiol. Rev. 19:259-282.
5. Brown-Elliott, B. A., S. C. Ward, C. J. Crist, L. B. Mann, R. W. Wilson, and R. J. Wallace, Jr. 2001. In vitro activities of linezolid against multiple Nocardia species. Antimicrob. Agents Chemother. 45:1295-1297.
6. Burgert, S. J. 1999. Nocardiosis: a clinical review. Infect. Dis. Clin. Pract. 8:27-32.
7. Conville, P. S., S. H. Fischer, C. P. Cartwright, and F. G. Witebsky. 2000. Identification of Nocardia species by restriction endonuclease analysis of an amplified portion of the 16S rRNA gene. J. Clin. Microbiol. 38:158-164.
8. Diekema, D. J., and R. N. Jones. 2001. Oxazolidinone antibiotics. Lancet 358:1975-1982.
9. Fung, H. B., H. L. Kirschenbaum, and B. O. Oofeitimi. 2001. Linezolid: an oxazolidinone antimicrobial agent. Clin. Ther. 23:356-391.
10. Glupczynski, Y., C. Berhin, M. Janssens, and G. Wauters. 2006. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin. Microbiol. Infect. 12:905-912.
11. Gómez-Flores, A., O. Welsh, S. Said-Fernández, G. Lozano-Garza, R. E. Tavarez-Alejandro, and L. Vera-Cabrera. 2004. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob. Agents Chemother. 48:832-837.
12. Laurent, F. J., F. Provost, and P. Boiron. 1999. Rapid identification of clinically relevant Nocardia species to the genus level by 16S rRNA gene PCR. J. Clin. Microbiol. 37:99-102.
13. NCCLS. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved standard. NCCLS document M24-A. NCCLS, Wayne, Pa.
14. Patel, J. B., R. J. Wallace, Jr., B. A. Brown-Elliot, T. Taylor, C. Imperatrice, D. G. B. Leonard, R. W. Wilson, L. Mann, K. C. Jost, and I. Nachamkin. 2004. Sequence-based identification of aerobic actinomycetes. J. Clin. Microbiol. 42:2530-2540.
15. Petersen P. J., N. V. Jacobus, W. J. Weiss, P. E. Sum, and R. T. Testa. 1999. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43:738-744.
16. Saubolle, M. A., and D. Sussland. 2003. Nocardiosis: review of clinical and laboratory experience. J. Clin. Microbiol. 41:4497-4501.
17. Steingrube V. A., B. A. Brown, J. L. Gibson, R. W. Wilson, J. Brown, Z. Blacklock, K. Jost, S. Locke, R. F. Ulrich, and R. J. Wallace, Jr. 1995. DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J. Clin. Microbiol. 33:3096-3101.
18. Steingrube V. A., R. W. Wilson, B. A. Brown, K. C. Jost, Jr., Z. Blacklock, J. L. Gibson, and R. J. Wallace, Jr. 1997. Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis. J. Clin. Microbiol. 35:817-822.
19. Tomlin P., C. Sand, and R. P. Rennie. 2001. Evaluation of E test, disk diffusion and broth microdilution to establish tentative quality control limits and review susceptibility breakpoints for two aerobic actinomycetes. Diagn. Microbiol. Infect. Dis. 40:179-186.
20. Vera-Cabrera, L., E. González, S. H. Choi, and O. Welsh. 2004. In vitro activities of new antimicrobials against Nocardia brasiliensis. Antimicrob. Agents Chemother. 48:602-604.
21. Wallace, R. J., Jr., L. C. Steele, G. Sumpter, and J. M. Smith. 1988. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob. Agents Chemother. 32:1776-1779.